Vascular Biogenics: The IPO That Wasn't

Now watching

Next video starts in : 7 Play

Vascular Biogenics: The IPO That Wasn't

Vascular Biogenics: The IPO That Wasn't
Replay video
Up next

Scotland stays; Ellison leaves; Alibaba gets ready for its close up

Scotland stays; Ellison leaves; Alibaba gets ready for its close up Up next

Scotland stays; Ellison leaves; Alibaba gets ready for its close up

Unlock your personal NFL Now stream by signing in to NFL.com

Vascular Biogenics: The IPO That Wasn't

WSJ Live 3:18 mins

It was the IPO that wasn't: A biotech firm hit the market and traded for six days, only to announce Friday that it wasn't issuing shares after all, thanks to a key investor's failure to follow through on a commitment to buy stock. Dan Strumpf joins MoneyBeat with Paul Vigna.

View Comments (1)